![](/img/cover-not-exists.png)
A series of bisaryl imidazolidin-2-ones has shown to be selective and orally active 5-HT2C receptor antagonists
Caroline J. Goodacre, Steven M. Bromidge, David Clapham, Frank D. King, Peter J. Lovell, Mike Allen, Lorraine P. Campbell, Vicky Holland, Graham J. Riley, Kathryn R. Starr, Brenda K. Trail, Martyn D.Volume:
15
Year:
2005
Language:
english
Pages:
5
DOI:
10.1016/j.bmcl.2005.08.004
File:
PDF, 144 KB
english, 2005